Iris Tanaka et al.
ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin
Nucleic Acids Research 2019, vol. 48, issue 5
doi: 10.1093/nar/gkz1213
![Logo France Génomique](https://www.france-genomique.org/wp-content/uploads/2019/03/logo-FG-blue-RVB-medium.png)
Iris Tanaka et al.
ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin
Nucleic Acids Research 2019, vol. 48, issue 5
doi: 10.1093/nar/gkz1213